Iridex (IRIX) Free Cash Flow (QoQ) (2011 - 2026)
Iridex (IRIX) Free Cash Flow (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.25 Bn | 6.27 Bn |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.42 Bn | 66.96 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.32 Bn | 43.65 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.18 Bn | 1.98 Bn |
| 7 | Dexcom | 28.46 Bn | 27.34 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Iridex | 15.20 Mn | 10.60 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -260.27% |
| Jan 3, 2026 | 168.09% |
| Sep 27, 2025 | -253.76% |
| Jun 28, 2025 | 64.67% |
| Mar 29, 2025 | 23.53% |
| Dec 28, 2024 | 52.87% |
| Sep 28, 2024 | -116.77% |
| Jun 29, 2024 | 18.35% |
| Mar 30, 2024 | -40.03% |
| Dec 30, 2023 | 39.54% |
| Sep 30, 2023 | -68.54% |
| Jul 1, 2023 | 59.91% |
| Apr 1, 2023 | -70.06% |
| Dec 31, 2022 | 39.69% |
| Oct 1, 2022 | 3.43% |
| Jul 2, 2022 | 11.13% |
| Apr 2, 2022 | -129.55% |
| Sep 26, 2020 | 123.80% |
| Jun 27, 2020 | -43.97% |
| Mar 28, 2020 | -651.04% |